Therefore, we concluded that SMY may ameliorate ISO-induced myocardial hypertrophy by regulating the HIF1a-PPAR pathway and the expression of downstream glycolipid metabolism-related proteins, thereby alleviating the disturbance of energy metabolism. This evidence concerns the gene PPARA and cardiac hypertrophy.